Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA approves initiation of Progen's phase I trial in Australia for PI-88

July 6, 1999

EntreMed extends angiogenesis research agreement with Children's Hospital of Boston

July 6, 1999

Alsterpaullone is a potent CDK1/cyclin B inhibitor and antitumor agent

July 5, 1999

Onyvax and Erasmus University reach prostate cancer agreement

July 5, 1999

The Liposome Company seeks approval for Evacet in the E.U.

July 2, 1999

NA-22598B1 and B2: novel anticancer compounds produced by Streptomyces

July 2, 1999

CRC selects water-soluble paclitaxel for phase I trial

July 2, 1999

CDK4-specific antisense oligodeoxynucleotides for inhibition of tumors

July 1, 1999

Coulter, SmithKline Beecham file BLA for Bexxar

July 1, 1999

5-Halo- or nitrate-substituted paclitaxels under study at Bristol-Myers Squibb

July 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...